Filip K Knop Selected Research

Cardiac Arrhythmias (Arrythmia)

12/2021	Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study.
7/2021	Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Filip K Knop Research Topics

Disease

140	Type 2 Diabetes Mellitus (MODY) 10/2022 - 09/2003
28	Obesity 11/2022 - 01/2011
27	Insulin Resistance 04/2022 - 09/2003
27	Body Weight (Weight, Body) 01/2022 - 07/2008
24	Weight Loss (Weight Reduction) 04/2022 - 08/2009
24	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 09/2003
21	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2022 - 04/2010
20	Hyperglycemia 01/2022 - 01/2008
14	Non-alcoholic Fatty Liver Disease 01/2022 - 04/2016
11	Overweight 01/2022 - 01/2011
9	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 01/2013
9	Glucose Intolerance 01/2020 - 05/2011
8	Inflammation (Inflammations) 11/2022 - 11/2015
8	Schizophrenia (Dementia Praecox) 01/2019 - 08/2012
7	Bone Resorption 01/2022 - 11/2014
7	Weight Gain 12/2021 - 07/2008
6	Nausea 11/2020 - 08/2009
6	Chronic Pancreatitis 09/2010 - 09/2003
5	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2017
5	Diabetes Complications 09/2020 - 02/2009
5	Liver Diseases (Liver Disease) 07/2019 - 01/2018
4	Dyslipidemias (Dyslipidemia) 01/2022 - 09/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 05/2016
4	Fibrosis (Cirrhosis) 02/2019 - 10/2015
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2019 - 04/2014
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 12/2011
3	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2020 - 10/2013
3	Alcoholic Fatty Liver 07/2020 - 01/2017
3	Neoplasms (Cancer) 07/2019 - 11/2016
3	Vomiting 01/2017 - 10/2014
3	Pancreatitis 01/2017 - 01/2015
2	Cardiac Arrhythmias (Arrythmia) 12/2021 - 07/2021
2	Necrosis 01/2020 - 01/2018
2	Fatty Liver 01/2020 - 10/2019
2	Glucagonoma 07/2019 - 01/2017
2	Cholecystitis 01/2019 - 12/2018
2	Hyperplasia 01/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

113	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 09/2003
63	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2021 - 09/2003
59	Glucagon (Glukagon)FDA Link 01/2022 - 01/2008
45	Insulin (Novolin)FDA Link 01/2022 - 09/2003
38	Hormones (Hormone)IBA 01/2022 - 12/2007
34	IncretinsIBA 12/2020 - 08/2007
29	Peptides (Polypeptides)IBA 10/2022 - 01/2007
25	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 08/2009
19	Liraglutide FDA Link 11/2021 - 05/2010
16	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020 - 01/2008
12	Metformin (Glucophage)FDA LinkGeneric 11/2021 - 12/2011
11	Exenatide (Byetta)FDA Link 01/2022 - 05/2010
11	Hypoglycemic Agents (Hypoglycemics)IBA 10/2021 - 07/2008
10	Glucagon Receptors (Glucagon Receptor)IBA 01/2022 - 01/2011
10	LipidsIBA 07/2020 - 05/2010
10	Bile Acids and Salts (Bile Acids)IBA 01/2018 - 01/2014
9	Antipsychotic Agents (Antipsychotics)IBA 12/2021 - 08/2012
8	Amino Acids FDA Link 01/2022 - 01/2017
8	C-PeptideIBA 01/2022 - 05/2010
7	Pharmaceutical PreparationsIBA 07/2020 - 01/2010
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2018
5	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2022 - 01/2011
5	Hemoglobins (Hemoglobin)IBA 01/2022 - 11/2016
5	gastric inhibitory polypeptide receptorIBA 01/2022 - 01/2019
5	lixisenatideIBA 03/2017 - 08/2009
4	Islet Amyloid PolypeptideIBA 04/2022 - 05/2010
4	CollagenIBA 05/2021 - 01/2018
4	Cholecystokinin (Pancreozymin)IBA 01/2021 - 11/2017
4	EnzymesIBA 01/2018 - 01/2007
3	Collagen Type I (Type I Collagen)IBA 01/2022 - 01/2020
3	semaglutideIBA 01/2022 - 03/2017
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
3	Alanine (L-Alanine)FDA Link 12/2020 - 01/2018
3	Hepatocyte Nuclear FactorsIBA 01/2020 - 07/2014
3	Blood Glucose (Blood Sugar)IBA 01/2018 - 03/2014
3	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 06/2014 - 01/2011
2	Sitagliptin Phosphate (Januvia)FDA Link 10/2022 - 01/2018
2	Islet Amyloid Polypeptide ReceptorsIBA 04/2022 - 01/2022
2	Calcitonin Receptors (Calcitonin Receptor)IBA 04/2022 - 01/2020
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 04/2022 - 01/2020
2	adomeglivantIBA 01/2022 - 12/2020
2	FructosamineIBA 01/2022 - 01/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 11/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2021 - 01/2019
2	gastric inhibitory polypeptide (3-30)-amideIBA 05/2021 - 01/2020
2	fibroblast growth factor 21IBA 05/2021 - 01/2018
2	Sodium-Glucose Transport ProteinsIBA 12/2020 - 02/2016
2	glimepiride (Amarel)FDA LinkGeneric 01/2020 - 07/2014
2	Ethanol (Ethyl Alcohol)IBA 01/2020 - 10/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
2	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 01/2020 - 10/2015
2	C-Reactive ProteinIBA 01/2020 - 09/2014
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2017

Therapy/Procedure

24	Therapeutics 04/2022 - 09/2003
13	Glycemic Control 10/2022 - 12/2011
10	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 12/2011
5	Drug Therapy (Chemotherapy) 04/2022 - 11/2017
5	Subcutaneous Injections 01/2022 - 09/2003
5	Intravenous Infusions 01/2022 - 04/2016
4	Bariatric Surgery 02/2019 - 12/2011
3	Renal Dialysis (Hemodialysis) 01/2022 - 01/2020
3	Injections 01/2021 - 01/2010
3	Oral Administration 01/2018 - 04/2010